- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01545414
Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease
February 12, 2015 updated by: Viktor Kaldo, Karolinska Institutet
Internet-based CBT for Depression and Anxiety in Parkinson's Disease: a Pilot Study and Randomized Controlled Trial
The purpose of this project is to develop and evaluate Internet-based Cognitive Behavioral Therapy (ICBT) for Parkinson's Disease (PD) patients with concurrent depression or anxiety symptoms.
All treatment in this project is given as an adjunct to Standard Medical Treatment (SMT).
ICBT will be compared to an Internet-based active control treatment (ICONTROL) and to SMT alone.
It is hypothesized that both active treatments will be superior to SMT, and that ICBT will be superior to ICONTROL, in reducing symptoms of depression and anxiety.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Stockholm, Sweden
- Internetpsykiatrienehten (Internet Psychiatry Unit), Psykiatri Sydväst, SLSO
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of Parkinson's Disease
- At least mild to moderate depression or anxiety defined as HADS-A or HADS-D > 7
Exclusion Criteria:
- Has a high alcohol or drug use assessed by the AUDIT / DUDIT and assessment interview
- Somatic or psychiatric problems that are directly contraindicated or seriously hamper the implementation of the treatment (eg, psychotic disorders or bipolar disorder)
- Difficulties that hamper the use of a computer
- The patient states difficulties in finding enough time for treatment
- Too low cognitive functioning defined as MoCA < 24
- Too severe depression, defined as MADRS-S over 30
- Too high suicidal risk defined as more than 4 points on the MADRS-S question 9 or according to the structured assessment interview
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ICBT
Internet-based Cognitive Behavioral Therapy with a focus on behavioral activation
|
12 weeks of Internet-based Cognitive Behavioral Therapy with a focus on behavioral activation
|
|
Active Comparator: ICONTROL
Internet-based treatment with a focus on relaxation training
|
12 weeks of Internet-based treatment with a focus on relaxation training
|
|
No Intervention: SMT
Standard Medical Treatment while being on the waitlist for randomization to any of the active treatments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change (from baseline) in HADS
Time Frame: 12 weeks (Post), 3 and 6 months (FU)
|
Hospital Anxiety and Depression Scale - self rating, to measure anxiety and depression
|
12 weeks (Post), 3 and 6 months (FU)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change (from baseline) in MADRS-S
Time Frame: 12 weeks (Post), 3 and 6 months (FU)
|
Montgomery and Asberg Depressions Rating Scale - Self report, to measure level of depression
|
12 weeks (Post), 3 and 6 months (FU)
|
|
Change (from baseline) in ISI
Time Frame: 12 weeks (Post), 3 and 6 months (FU)
|
Insomnia Severity Index - self-report, to measure insomnia symptoms
|
12 weeks (Post), 3 and 6 months (FU)
|
|
Change (from baseline) in PDQ-8
Time Frame: 12 weeks (Post), 3 and 6 months (FU)
|
The Parkinson's Disease Questionnaire-8, to measure various health aspects specific for PD patients
|
12 weeks (Post), 3 and 6 months (FU)
|
|
Change (from baseline) in EQ-5D
Time Frame: 12 weeks (Post), 3 and 6 months (FU)
|
EQ-5D, to measure general health and quality of life
|
12 weeks (Post), 3 and 6 months (FU)
|
|
Change (from baseline) in SDS
Time Frame: 12 weeks (Post), 3 and 6 months (FU)
|
Sheehan Disability Scale, to measure everyday level of functioning
|
12 weeks (Post), 3 and 6 months (FU)
|
|
Change (from baseline) in NMSQuest
Time Frame: 12 weeks (Post), 3 and 6 months (FU)
|
Non-Motor Symptoms Questionnaire, to measure the non-motor symptoms in PD
|
12 weeks (Post), 3 and 6 months (FU)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Viktor Kaldo, Ph.D., Karolinska Institutet
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
August 1, 2013
Study Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
March 1, 2012
First Submitted That Met QC Criteria
March 5, 2012
First Posted (Estimate)
March 6, 2012
Study Record Updates
Last Update Posted (Estimate)
February 13, 2015
Last Update Submitted That Met QC Criteria
February 12, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ICBT Parkinson
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
Fondation FondaMentalGYNOVNot yet recruitingDepression | Depression in Adults | Depression DisorderFrance
Clinical Trials on ICBT
-
University of ReginaCanadian Institutes of Health Research (CIHR)Completed
-
National University of SingaporeAgency for Integrated Care, Singapore; MOH Office for Healthcare Transformation...Not yet recruitingCognitive Behavioral Therapy | Depression and/or Anxiety in the Mild-to-moderate RangeSingapore
-
Region of Southern DenmarkRecruitingDepression - Major Depressive DisorderDenmark
-
Vastra Gotaland RegionCompletedAnxiety Disorders and Symptoms | Internet-Based InterventionSweden
-
University of ReginaCompletedDepression | Anxiety | Chronic DiseaseCanada
-
Hospital Clinic of BarcelonaNot yet recruitingObsessive-Compulsive Disorder (OCD)
-
Linkoeping UniversityCompleted
-
Joaquim RaduaCompleted
-
Karolinska InstitutetRegion StockholmCompletedInternet-based Cognitive Behavioral Therapy for Adolescents With Sleep Problems- a Feasibility TrialDepressive Disorder | Inflammation | Anxiety Disorders | Pain, Chronic | Insomnia DisorderSweden
-
Linkoeping UniversityStockholm UniversityCompletedGeneralized Anxiety DisorderSweden